1Libby P, Ridker PM, Maseri A. Inflammation and atherosclercsis. Circulation, 2002, 105: 1135-1143.
2Kharbanda RK, Walton B, Allen M, et al. Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin.Circulation, 2002, 105: 2600-2604.
3Nakajima T, Schuhe S, Warrington KJ, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation, 2002, 105: 570-575.
4Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleuldn-6 inhibition attenuate the proatherogenic effects of C-reactlve protein.Circulation. 2002, 105: 1890-1896.
5Sampietro T, Bigazzi F, Dal Pino B, et al. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammation condition? Circulation, 2002, 105: 11-14.
6Rajamannan NM, Subramanian M, Springett M, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation, 2002, 105: 2660-2665.
7Hayaishi-Okano R, Yamaski Y, Katakami N, et al. Elevated C-reactive protein associates witheady-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care, 2002, 25: 1432-1438.
8Prasad A, Zhu J, Halcox JP, et al. Predisposition to atheroscleroeis by infections: role of endothelial dysfunction. Circulation, 2002, 106: 184-190.
9Parchure N, Zouridakis EG, Kaski JC. Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. Circulation, 2002, 105: 1298-1303.
10Wiesli P, Czerwenka W, Meniconi A, et al. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial. Circulation, 2002, 105: 2646-2652.
